Table 1 Summary of baseline patient details
Characteristics | |
|---|---|
No. of participants | 182 |
No. of eyes | 207 |
Mean age (years) ± SD | 80 ± 7.7 |
Female (%) | 71 |
Phakic eyes (%) | 78 |
Mean BCVA (letters) ± SD | 29 ±13.2 |
Mean central retinal thickness (μm) ± SD | 342 ± 100 |
Mean duration of nvAMD at switch (weeks) ± SD | 129 ± 86 |
Mean number of ranibizumab injections at switch ± SD | 12 ± 7 |